Philip M. McKenna

机构：Merck & Co., Inc., Rahway, NJ, USA (United States)

发表论文 35 篇 · 总被引 1745 次 · h-index 21

代表论文

• The Macaque Gut Microbiome in Health, Lentiviral Infection, and Chronic Enterocolitis (2008 · PLoS Pathogens · 被引 441)
• SARS-CoV-2 tropism, entry, replication, and propagation: Considerations for drug discovery and development (2021 · PLoS Pathogens · 被引 217)
• The consequence of passive administration of an anti-human immunodeficiency virus type 1 neutralizing monoclonal antibody before challenge of chimpanzees with a primary virus isolate (1996 · Journal of Virology · 被引 137)
• Second-Generation Rabies Virus-Based Vaccine Vectors Expressing Human Immunodeficiency Virus Type 1 Gag Have Greatly Reduced Pathogenicity but Are Highly Immunogenic (2002 · Journal of Virology · 被引 97)
• Recombinant Human Monoclonal Antibody IgG1b12 Neutralizes Diverse Human Immunodeficiency Virus Type 1 Primary Isolates (1997 · AIDS Research and Human Retroviruses · 被引 80)
• Functional Human Immunodeficiency Virus Type 1 (HIV-1) Gag-Pol or HIV-1 Gag-Pol and Env Expressed from a Single Rhabdovirus-Based Vaccine Vector Genome (2003 · Journal of Virology · 被引 69)